This trust offers the following services:

• Acute services:
• On-site bowel stenting facilities

• Diagnostic and pre-operative services:
• On-site MRI liver facilities
• Routine Genetic Testing for Lynch Syndrome

• Oncology services:
• On-site chemotherapy services

• Advanced disease services:
• Dedicated Specialist Advanced MDT

• Support service facilities:
• Availability of 24 hour palliative care advice

All Patients:	Trust	Network	National
Number of patients in Audit	156	3445	31676
Case ascertainment (%)	113	100	95
Data completeness of:
– Pre-treatment TNM (%)	69	79	80
– Performance status (%)	78	88	86

Patients having major resection:	Trust	Network	National
Number of patients in Audit	110	2169	19218
ASA grade 1 (%)	13	11	11
ASA grade 2 (%)	53	53	53
ASA grade 3 (%)	26	30	28
ASA grade 4+ (%)	5	3	3
ASA grade not recorded (%)	3	3	5
Data completeness of:
7 Audit items for risk-adjustment (%)	95	82	86

All Patients:	Trust	Network	National
Number of patients in Audit	156	3445	31676
Seen by Clinical Nurse Specialist (%)	92	88	87

All patients deemed potentially curative	Trust	Network	National
Number of potentially curative patients	46	845	7416
Undergoing major resection (%)	96	88	86

Patients having major resection:	Trust	Network	National
Number of patients in Audit	110	2169	19218
Distant metastases (%)	12	9	8
Urgent or emergency surgery (%)	19	17	15
At least 12 lymph nodes excised (%)	76	77	84
Laparoscopic surgery attempted (%)	84	74	69
Risk-adjusted length of stay > 5 days (%)	55	58	62

Patients having major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	61	1249	11837
Adjuvant chemotherapy (%)	57	71	62

Patients having major resection:	Trust	Network	National
Number of patients in Audit	22	535	4588
Neoadjuvant therapy (%)	36	31	33
Circumferential resection margin: Recorded (%)	100	88	90
Circumferential resection margin: Negative (%)	100	80	80
Rectal volume	N/A	N/A	N/A

Patients in APER/Hartmanns estimate:	Trust	Network	National
Number of patients in APER/Hartmanns estimate	N/A	N/A	N/A
APER/Hartmanns (%)	N/A	N/A	N/A